T. Rowe Price Associates, Inc. 13D and 13G filings for Bio-Techne Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | Bio-Techne Corporation TECH | T. Rowe Price Associates, Inc. | 3,350,818 2.200% | -5,497,332 (-62.13%) | Filing |
| 2025-08-14 1:07 pm Sale | 2025-06-30 | 13G | Bio-Techne Corporation TECH | T. Rowe Price Associates, Inc. | 8,848,150 5.600% | -2,535,457 (-22.27%) | Filing |
| 2025-05-14 10:45 am Purchase | 2025-03-31 | 13G | Bio-Techne Corporation TECH | T. Rowe Price Associates, Inc. | 11,383,607 7.200% | 1,959,294 (+20.79%) | Filing |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Bio-Techne Corporation TECH | T. Rowe Price Associates, Inc. | 9,424,313 5.900% | 9,424,313 (New Position) | Filing |